In 1984 C.E., a materials engineer working late nights in an ultraviolet-light lab at a Southern California furniture company did something that would quietly restructure manufacturing, medicine, and design: he filed a patent for a process that could turn liquid resin into a solid, three-dimensional object, layer by layer, using a focused beam of UV light. Chuck Hull called it stereolithography — from the Greek for “solid” and “writing in stone” — and the world has never built things quite the same way since.
What the evidence shows
- Stereolithography patent: Hull filed his patent application in 1984 C.E.; it was granted in 1986 C.E., making it the first legally recognized intellectual property claim on a workable 3D printing process in the United States.
- 3D printing history: Japanese researcher Hideo Kodama had pioneered the layered UV-curing approach in the early 1980s C.E., and a French team — Alain Le Mehaute, Olivier de Witte, and Jean Claude André — filed a competing stereolithography patent in 1984 C.E. just before Hull; their application was abandoned by corporate sponsors, a loss that went largely unnoticed for decades.
- Additive manufacturing commercialization: After his patent was granted, Hull co-founded 3D Systems, the world’s first commercial 3D printing company, translating the laboratory process into an industry.
How stereolithography actually works
The core idea is elegant. A vat of liquid photopolymer resin sits beneath a UV laser guided by computer-aided design software. The laser traces the first cross-section of an object onto the resin’s surface. Where the light touches, chemical monomers cross-link and solidify. The platform drops a fraction of a millimeter, a fresh layer of liquid resin covers the surface, and the laser traces the next cross-section.
This repeats — sometimes thousands of times — until a complete three-dimensional object emerges from the liquid. Desktop versions of the machine invert the process, pulling the object upward through the bottom of a transparent vat, which allows the build volume to exceed the vat’s own size.
The resulting parts are remarkably precise. Complex geometries that would be impossible to mill or cast can be printed in hours. Research published in peer-reviewed additive manufacturing journals has documented tolerances that rival traditional machining for many applications.
From automotive prototypes to surgical planning
Hull’s original intent was practical and specific: let engineers hold a physical prototype of a design before committing to expensive tooling. The automotive industry became an early adopter, using stereolithography to test components without producing full molds — dramatically compressing product development cycles.
But medicine turned out to be among the most consequential applications. By the 1990s C.E., hospitals were using stereolithographic models built from CT and MRI scans to create patient-specific anatomical replicas. Surgeons could rehearse complex osteotomies on a physical model of a patient’s actual bone structure before making a single incision. Prosthetists could design custom implants, including cranioplasty plates fitted to individual skull geometries, with a precision that earlier manufacturing methods simply could not match.
In 2019 C.E., scientists at Rice University published research in Science demonstrating soft hydrogel stereolithography for biological tissue applications — opening pathways toward printed human tissue and, potentially, organ scaffolding.
Lasting impact
Stereolithography was the seed of an entire manufacturing philosophy: additive rather than subtractive, building up instead of cutting away. That shift has propagated into fused deposition modeling, selective laser sintering, and dozens of other 3D printing technologies now used in aerospace, consumer goods, pharmaceuticals, and architecture.
The broader concept of additive manufacturing now represents a multi-billion-dollar global industry. Parts that once required weeks of machining and specialized tooling can be produced overnight. Small manufacturers and independent designers can access production capabilities that were once limited to large industrial facilities.
Hull’s work also helped catalyze a democratization of making. Desktop SLA printers — compact, affordable descendants of that first UV-vat machine — now sit in architecture studios, dental labs, classrooms, and small workshops around the world. The lineage from Hull’s 1984 C.E. patent to today’s consumer 3D printing ecosystem is direct and well-documented.
Blindspots and limits
The standard origin story of 3D printing centers almost entirely on Hull. Kodama’s earlier layered-curing work in Japan and the French team’s near-simultaneous patent application deserve more recognition in that history — the French inventors, in particular, lost their claim not through inferior science but through corporate indifference.
Stereolithography itself carries real constraints: resin materials can be expensive and chemically hazardous, finished parts require solvent washing, and the photopolymers used in most SLA printing are thermoset plastics that are difficult to recycle. Researchers are actively developing greener and reusable resin formulations, but sustainable SLA at scale remains an open problem.
Read more
For more on this story, see: Stereolithography — Wikipedia
For more from Good News for Humankind, see:
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- Renewables now make up at least 49% of global power capacity
- The Good News for Humankind archive on technology
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
China plans to double its already massive clean energy supply by 2035
China’s new climate pledge to the United Nations sets a target of 3,600 gigawatts of wind and solar power by 2035 — more than the entire electricity-generating capacity of the United States today, and roughly double what China has already built. The commitment is woven into the country’s next Five-Year Plan, which directs state banks, provinces, and manufacturers to move in the same direction. Because China makes about 80% of the world’s solar panels, every factory it scales up makes clean energy cheaper for buyers in Africa, Southeast Asia, Latin America, and everywhere else. That ripple effect is what makes…
-
Doctors hail first breakthrough in asthma and COPD treatment in 50 years
Benralizumab, a single injection given during an asthma or COPD attack, outperformed the steroid pills that have been the only emergency option since the 1970s. In a King’s College London trial of 158 patients, those who got the shot had four times fewer treatment failures over 90 days, along with easier breathing and fewer follow-up visits. Because steroids carry real risks with repeated use — diabetes, osteoporosis, and more — a genuine alternative could change daily life for millions of people who live in fear of the next flare-up. After a half-century of stalled progress on diseases that claim 3.8…
-
Mexico launches universal healthcare for all 133 million citizens
Mexico universal healthcare is now officially a reality, with the country launching a system designed to cover all 133 million citizens through the restructured IMSS-Bienestar network. Before this reform, an estimated 50 million Mexicans had no formal health insurance, with rural and Indigenous communities bearing the heaviest burden of untreated illness and medical debt. The new system severs the long-standing tie between employment and healthcare access, providing free consultations, medicines, and hospital services regardless of income. If implemented effectively, Mexico’s move could serve as a powerful model for other middle-income nations still navigating fragmented, inequitable health systems.
